1. Skip to content

Mesothelioma Cancer Resources Blog

  • FDA Orphan Designation Given to Tremelimumab, Promising Mesothelioma Therapy

    The mesothelioma community has seen an increase in research breakthroughs recently. The trend continues with the news that another drug for mesothelioma treatment has received Orphan Drug Designation from the U.S. Food and Drug Administration. Just last month CRS-207, an immuno-oncology product candidate for the treatment of mesothelioma, received the same designation. According to an …

    Label: Featured Story

    Posted on Monday, Apr 27, 2015
  • Mesothelioma Patients Could Benefit from Beeping Laser That Guides Surgeons During Intricate Cancer Surgery

    Researchers continue to get more and more creative when it comes to developing tools to help surgeons identify and remove tumors and cancer cells more thoroughly and effectively. Already, University of Pennsylvania researchers have found a way to get cancerous tissues to glow under an infrared light guiding surgeons to the diseased cells. Now, researchers …

    Label: Featured Story

    Posted on Monday, Apr 20, 2015
  • AllTrials Fights for Clinical Trial Transparency

    Clinical trials are critically important to mesothelioma patients, and MesotheliomaHelp strives to bring key trial information to our readers. Today, we are following up on a previous article on the report from Duke University about trial results being underreported, with information regarding a global campaign undertaken to fix this problem. For rare diseases, such as …

    Label: Featured Story

    Posted on Thursday, Apr 16, 2015
Load More News